MedPath

Megace ES

MEGACE ES (megestrol acetate oral suspension) suspension

Approved
Approval ID

33bc102c-31a3-4fd9-9702-c1193d7699a3

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 27, 2009

Manufacturers
FDA

Stat Rx USA

DUNS: 786036330

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

MEGESTROL ACETATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16590-254
Application NumberNDA021778
Product Classification
M
Marketing Category
C73594
G
Generic Name
MEGESTROL ACETATE
Product Specifications
Route of AdministrationORAL
Effective DateOctober 27, 2009
FDA Product Classification

INGREDIENTS (1)

MEGESTROL ACETATEActive
Quantity: 125 mg in 1 mL
Code: TJ2M0FR8ES
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.